“…To our knowledge, this is the first study to investigate this question specifically amongst EDPs providing care to COVID-19 infected individuals post vaccination roll-outs. Early in the COVID-19 pandemic, there were several studies that evaluated for the presence of SAR-CoV-2 antibodies in HCWs, reporting a prevalence ranging from 5 to 42% [ [1] , [2] , [3] , 10 ]. Important to note that this was a time many institutions lacked appropriate PPE.…”